Presently, the female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Afghanistan stands at 36.2%, an increase of 0.2% (0.6%) since 2018.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Afghanistan
No matching regions
Data currently not available for this time and region, try a different time period
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Afghanistan
Female CVD, cancer, diabetes or CRD
More indicators for Afghanistan
Out-of-pocket expenditure PPP per capita
intl dollar281
intl dollar39
(2021)
Newborns protected against tetanus
60%
5%
(2022)
Female wasting in children
3.5%
0.6%
(2022)
Birth registration
42.3%
4.9%
(2015)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
19.8%
0%
(2016)
Afghanistan Female CVD, cancer, diabetes or CRD between 2000 and 2019
Period | Female CVD, cancer, diabetes or CRD | Change |
---|---|---|
2019 | 36.2% | 0.2% |
2018 | 36% | 0.1% |
2017 | 35.9% | 0.1% |
2016 | 36% | 0.3% |
2015 | 35.7% | 0% |
2014 | 35.7% | 0.4% |
2013 | 36.1% | 0.2% |
2012 | 36.3% | 0.5% |
2011 | 36.8% | 0.6% |
2010 | 37.4% | 0.4% |
2009 | 37.8% | 1.1% |
2008 | 38.9% | 0.6% |
2007 | 39.5% | 0.3% |
2006 | 39.8% | 0.2% |
2005 | 40% | 0.2% |
2004 | 40.2% | 0.1% |
2003 | 40.1% | 0.4% |
2002 | 40.5% | 0.4% |
2001 | 40.1% | 0.7% |
2000 | 39.4% |